pioglitazone has been researched along with atrial natriuretic factor in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 8 (80.00) | 29.6817 |
2010's | 2 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Asakawa, M; Hasegawa, H; Kadowaki, T; Komuro, I; Kubota, N; Masuda, Y; Nagai, T; Saito, T; Takano, H; Uozumi, H | 1 |
Ito, S; Ogawa, S; Takeuchi, K | 1 |
Brunner, HR; Burnier, M; Chiolero, A; Maillard, M; Nussberger, J; Zanchi, A | 1 |
Kahara, T; Kaneko, S; Misaki, T; Sakurai, M; Shimizu, A; Takamura, T; Takeshita, Y | 1 |
Sheng, L; Wu, SM; Yang, W; Ye, P | 1 |
Huang, F; Li, Z; Liu, J; Liu, Z; Wang, H; Xing, Z | 1 |
Cheng, XW; Kato, MF; Koike, Y; Miyachi, M; Murate, T; Murohara, T; Nagata, K; Nishizawa, T; Noda, A; Obata, K; Shibata, R; Tsuboi, K; Yamada, T; Yazawa, H; Yokota, M | 1 |
Boomsma, F; de Boer, RA; Kuipers, I; Martens, FM; Visseren, FL | 1 |
Bekeredjian, R; Buss, SJ; Hagenmüller, M; Hardt, SE; Katus, HA; Münz, S; Ochs, M; Pichler, M; Weiss, CS | 1 |
Liu, YX; Wu, SM; Ye, P; Zhang, C | 1 |
3 trial(s) available for pioglitazone and atrial natriuretic factor
Article | Year |
---|---|
Plasma BNP levels in the treatment of type 2 diabetes with pioglitazone.
Topics: Aged; Atrial Natriuretic Factor; Body Mass Index; Buformin; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Heart Failure; Humans; Hypoglycemic Agents; Male; Middle Aged; Natriuretic Peptide, Brain; Pioglitazone; Stroke Volume; Thiazoles; Thiazolidinediones | 2003 |
Effects of the peroxisomal proliferator-activated receptor-gamma agonist pioglitazone on renal and hormonal responses to salt in healthy men.
Topics: Adult; Aldosterone; Atrial Natriuretic Factor; Blood Pressure; Cross-Over Studies; Diet, Sodium-Restricted; Humans; Hypoglycemic Agents; Male; Pioglitazone; Placebos; Receptors, Cytoplasmic and Nuclear; Renal Circulation; Renin; Sodium Chloride; Thiazolidinediones; Transcription Factors | 2004 |
The effects of the PPAR-gamma agonist pioglitazone on plasma concentrations of circulating vasoactive factors in type II diabetes mellitus.
Topics: Aldosterone; Amine Oxidase (Copper-Containing); Atrial Natriuretic Factor; Cross-Over Studies; Diabetes Mellitus, Type 2; Endothelins; Humans; Hypoglycemic Agents; Pioglitazone; PPAR gamma; Renin; Thiazolidinediones | 2010 |
7 other study(ies) available for pioglitazone and atrial natriuretic factor
Article | Year |
---|---|
Peroxisome proliferator-activated receptor gamma plays a critical role in inhibition of cardiac hypertrophy in vitro and in vivo.
Topics: Actins; Angiotensin II; Animals; Atrial Natriuretic Factor; Body Weight; Cardiomegaly; Cell Size; Cells, Cultured; Chromans; Disease Models, Animal; Gene Expression; Heart; Heterozygote; Hypoglycemic Agents; Ligands; Mice; Mice, Knockout; Myocardium; Organ Size; Pioglitazone; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone | 2002 |
Relationship between plasma hANP level and pretibial edema by pioglitazone treatment.
Topics: Aged; Aged, 80 and over; Atrial Natriuretic Factor; Diabetes Mellitus, Type 2; Edema; Female; Humans; Hypoglycemic Agents; Male; Middle Aged; Pioglitazone; Thiazolidinediones; Tibia | 2005 |
Effect of pioglitazone on the expression of inflammatory cytokines in attenuating rat cardiomyocyte hypertrophy.
Topics: Angiotensin II; Animals; Anti-Inflammatory Agents; Atrial Natriuretic Factor; Cardiomegaly; Cells, Cultured; Interleukin-1beta; Interleukin-6; Leucine; Myocytes, Cardiac; Natriuretic Peptide, Brain; Pioglitazone; PPAR gamma; Rats; Rats, Wistar; RNA, Messenger; Thiazolidinediones | 2006 |
Pioglitazone inhibits hypertrophy induced by high glucose and insulin in cultured neonatal rat cardiomyocytes.
Topics: Animals; Animals, Newborn; Atrial Natriuretic Factor; Cardiomegaly; Cell Size; Cells, Cultured; Cytokines; Glucose; Hypoglycemic Agents; Insulin; Muscle Proteins; Myocytes, Cardiac; Pioglitazone; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thiazolidinediones | 2007 |
Pioglitazone attenuates cardiac hypertrophy in rats with salt-sensitive hypertension: role of activation of AMP-activated protein kinase and inhibition of Akt.
Topics: Adiponectin; AMP-Activated Protein Kinases; Animals; Atrial Natriuretic Factor; Collagen; Echocardiography; Fibrosis; Hypertension; Hypertrophy, Left Ventricular; Hypoglycemic Agents; Male; Multienzyme Complexes; Myocardium; Myocytes, Cardiac; Natriuretic Peptide, Brain; Phosphorylation; Pioglitazone; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Inbred Dahl; Ribosomal Protein S6 Kinases, 70-kDa; RNA, Messenger; Signal Transduction; Thiazolidinediones; Transcription Factors | 2008 |
Activation of PPARgamma by pioglitazone does not attenuate left ventricular hypertrophy following aortic banding in rats.
Topics: Animals; Aorta, Thoracic; Atrial Natriuretic Factor; Disease Models, Animal; Echocardiography; Hypertrophy, Left Ventricular; Hypoglycemic Agents; Male; Myocytes, Cardiac; Pioglitazone; PPAR gamma; Rats; Rats, Wistar; Thiazolidinediones; Ventricular Function, Left | 2010 |
[Pioglitazone inhibits cardiac hypertrophy of rats in vitro and in vivo].
Topics: Animals; Atrial Natriuretic Factor; Cardiomegaly; Cell Line; Cytokines; Disease Models, Animal; Interleukin-1beta; Male; Myocytes, Cardiac; Natriuretic Peptide, Brain; Pioglitazone; Rats; Rats, Sprague-Dawley; RNA, Messenger; Thiazolidinediones | 2005 |